It is obvious that for any immunomodulatory strategy to be successful, further large placebo-controlled trials are needed. The criterion for these trials should be to clearly disclose at which ...

Despite advances in supportive care of critically ill patients, sepsis remains an important cause of death worldwide. More than 750,000 individuals develop severe sepsis in North America annually ...